Please login to the form below
11
Revenue 2017AstraZeneca
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
Finalists 2023
for AstraZeneca, GAAPP, IFA, Chiesi. Pioneering a ‘Pfizer first’ to Deliver Above-brand Messages. ... for AstraZeneca UK. Now I Know. by Ogilvy Health UK. for National Autistic Society.
Crick Institute announces new molecular glue discovery to treat different diseases
The £11.2m research investment includes funds from AstraZeneca and the EPSRC. ... A combined investment of £11.2m that includes a prosperity partnership grant from the Engineering and Physical Sciences Research Council (EPSRC) and funds from
AstraZeneca’s heart failure treatment recommended by NICE for expanded use
AstraZeneca’s (AZ) Forixga (dapagliflozin) has been recommended for extended use by the National Institute for Health and Care Excellence (NICE), meaning adult patients with heart failure (HF) can benefit from
AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
AstraZeneca (AZ) has announced positive results from a phase 3 trial evaluating Tagrisso (osimertinib) in combination with chemotherapy in certain lung cancer patients.
AstraZeneca’s heart failure treatment approved for expanded use in US
AstraZeneca’s (AZ) Farixga (dapagliflozin) has been approved for extended use in the US, meaning adult patients with heart failure (HF) can benefit from the treatment regardless of their left ventricular ... Ruud Dobber, executive vice-president,
[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
AMICULUM
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
